Drug intelligence / Profile preview

metoprolol succinate extended-release (Dr. Reddy's)

Development stage
Unknown
Lead developer
Dr. Reddy's Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Metoprolol succinate is a cardioselective beta-1 adrenergic receptor blocker used primarily for the treatment of hypertension, angina pectoris, and stable heart failure. As a small molecule antagonist, it selectively binds to beta-1 receptors in cardiac tissue, leading to a reduction in heart rate, cardiac contractility, and systemic blood pressure. The specific entity generic a-University of Florida-hypertension refers to the generic metoprolol extended-release formulation manufactured by Dr. Reddy's Laboratories, which was evaluated in a University of Florida clinical trial (NCT01830309) comparing its pharmacokinetic and pharmacodynamic profiles against the brand-name drug Toprol XL. This study aimed to address concerns regarding the bioequivalence and clinical consistency of generic metoprolol ER products in patients with hypertension.

Other names
metoprolol succinate ERmetoprolol succinategeneric a-University of Florida-hypertension
02

Targets

ADRB2 (β2)ADRB1 (β1)

Beyond the preview

Go deeper on metoprolol succinate extended-release (Dr. Reddy's).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metoprolol succinate extended-release (Dr. Reddy's).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call